This company has been acquired
Science 37 Holdings Past Earnings Performance
Past criteria checks 0/6
Science 37 Holdings's earnings have been declining at an average annual rate of -46.3%, while the Life Sciences industry saw earnings growing at 16.4% annually. Revenues have been growing at an average rate of 23.9% per year.
Key information
-46.3%
Earnings growth rate
36.9%
EPS growth rate
| Life Sciences Industry Growth | 21.5% |
| Revenue growth rate | 23.9% |
| Return on equity | -240.9% |
| Net Margin | -206.9% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks
Dec 18
Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)
Apr 17Science 37, Syapse team for faster patient enrollment in cancer trials
Aug 18Science 37 reports Q2 mixed earnings; narrows FY22 guidance
Aug 11Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
May 13Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans
Apr 11Science 37: Pioneering Decentralized Clinical Trials
Jan 02We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth
Nov 04Revenue & Expenses Breakdown
How Science 37 Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 60 | -125 | 76 | 0 |
| 30 Jun 23 | 62 | -134 | 86 | 0 |
| 31 Mar 23 | 66 | -121 | 97 | 0 |
| 31 Dec 22 | 70 | -51 | 107 | 0 |
| 30 Sep 22 | 75 | -50 | 121 | 0 |
| 30 Jun 22 | 73 | -41 | 113 | 0 |
| 31 Mar 22 | 66 | -43 | 97 | 0 |
| 31 Dec 21 | 60 | -94 | 76 | 0 |
| 30 Sep 21 | 50 | -42 | 54 | 0 |
| 30 Jun 21 | 43 | -35 | 44 | 0 |
| 31 Mar 21 | 33 | -33 | 38 | 0 |
| 31 Dec 20 | 24 | -32 | 34 | 0 |
| 31 Dec 19 | 14 | -18 | 23 | 0 |
Quality Earnings: SNCE is currently unprofitable.
Growing Profit Margin: SNCE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SNCE is unprofitable, and losses have increased over the past 5 years at a rate of 46.3% per year.
Accelerating Growth: Unable to compare SNCE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SNCE is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-7.9%).
Return on Equity
High ROE: SNCE has a negative Return on Equity (-240.9%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/03/11 13:59 |
| End of Day Share Price | 2024/03/11 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Science 37 Holdings, Inc. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Coldwell | Baird |
| Matthew Hewitt | Craig-Hallum Capital Group LLC |
| Frank Takkinen | Lake Street Capital Markets, LLC |